Wenisch C, Parschalk B, Zedwitz-Liebenstein K, Wernsdorfer W, Graninger W
Department of Infectious Diseases, Internal Medicine I, University Hospital of Vienna, Austria.
J Antimicrob Chemother. 1997 Jan;39(1):99-101. doi: 10.1093/jac/39.1.99.
The effect of dihydroartemisinin, artemisinin and artesunate (0.1, 0.5, 5 and 50 mg/L) on phagocytic function and release of reactive oxygen products by neutrophils was studied by flow cytometry. Incubation with dihydroartemisinin, artemisinin and artemether resulted in a decreased capacity to phagocytose Escherichia coli (0.1-50 mg/L: 62-40%, 66-32% and 59-47% of the control values, respectively; P < 0.001 for all). Conversely, the derivatives enhanced the intracellular generation of reactive oxygen intermediates (0.1-50 mg/L: 146-140%, 174-197% and 188-136% of the control values, respectively; P < 0.001 for all). Artemisia derivatives enhance the reactive oxygen response of neutrophils but depress their phagocytic ability at therapeutic blood levels.
通过流式细胞术研究了双氢青蒿素、青蒿素和青蒿琥酯(0.1、0.5、5和50毫克/升)对中性粒细胞吞噬功能和活性氧产物释放的影响。用双氢青蒿素、青蒿素和蒿甲醚孵育导致吞噬大肠杆菌的能力下降(0.1 - 50毫克/升:分别为对照值的62 - 40%、66 - 32%和59 - 47%;所有P < 0.001)。相反,这些衍生物增强了活性氧中间体的细胞内生成(0.1 - 50毫克/升:分别为对照值的146 - 140%、174 - 197%和188 - 136%;所有P < 0.001)。青蒿衍生物在治疗血药浓度下增强中性粒细胞的活性氧反应,但抑制其吞噬能力。